Interest in I-PrEP and Willingness to Participate in Clinical Trials Among Men and Transfeminine Persons Who have Sex with Men in Sub-Saharan Africa: Quantitative and Qualitative Findings from HPTN 075.

Journal: AIDS and behavior

Volume: 

Issue: 

Year of Publication: 

Affiliated Institutions:  HIV Center for Clinical and Behavioral Studies, Department of Psychiatry, New York State Psychiatric Institute and Columbia University, Riverside Drive, Unit , New York, NY, , USA. tgs@cumc.columbia.edu. Community Health and Social Sciences Department, Graduate School of Public Health and Health Policy, City University of New York (CUNY), New York, USA. Kenya Medical Research Institute (KEMRI) CDC, Kisumu, Kenya. Desmond Tutu HIV Centre, Cape Town, South Africa. Perinatal HIV Research Unit, University of the Witwatersrand, Soweto, South Africa. College of Medicine-Johns Hopkins Research Project, Blantyre, Malawi. Science Facilitation Department, FHI , Durham, NC, USA. Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Abstract summary 

This study explored interest in injectable PrEP (I-PrEP) and willingness to participate in clinical trials testing new biomedical HIV prevention strategies among men and transfeminine persons who have sex with men (MSM & TGP), using data collected in the HIV Prevention Trials Network (HPTN) 075 study, which took place at sites in Kenya, Malawi, and South Africa. Data result from a survey among 267 18-44 years old HIV negative participants, complemented with semi-structured interviews with 80 purposively recruited persons. Correlations coefficients were calculated to identify demographic and psychosocial factors associated with interest in I-PrEP. Qualitative interviews were analyzed using concept-driven and subsequent data-driven coding. Most surveyed participants expressed an interest in I-PrEP. Quantitatively, only being interested in other HIV prevention measures was associated with interest in I-PrEP. Qualitatively, most participants preferred I-PrEP to O-PrEP and remained interested in I-PrEP despite barriers such as the somewhat invasive nature of the procedure and potential side effects of I-PrEP. Interest in I-PrEP was driven by the possibility of avoiding sexual or HIV stigma. Access to healthcare and altruism-such as assisting in the development of new HIV prevention methods-positively impacted willingness to participate in clinical trials. With I-PrEP favored by most participants, it is potentially a critical tool to prevent HIV infection among MSM & TGP in sub-Saharan Africa, with the mitigation of stigma as a major advance. Recruitment of MSM & TGP in biobehavioral clinical trials seems feasible, with altruistic reasons and receiving I-PrEP and free medical care as major motivators.

Authors & Co-authors:  Sandfort Theodorus G M TGM Kreniske Philip P Mbeda Calvin C Reynolds Doerieyah D Tshabalala Gugulethu G Madiwati Blessings B Ogendo Arthur A Dominquez Karen K Panchia Ravindre R Gondwe Daniel D Hamilton Erica L EL Guo Xu X Cummings Vanessa V

Study Outcome 

Source Link: Visit source

Statistics
Citations :  Gouws E, Cuchi P. Focusing the HIV response through estimating the major modes of HIV transmission: a multi-country analysis. Sex Transm Infect. 2012;88(Suppl 2):i76–85. https://doi.org/10.1136/sextrans-2012-050719 .
Authors :  13
Identifiers
Doi : 10.1007/s10461-024-04334-x
SSN : 1573-3254
Study Population
Male,Female
Mesh Terms
Other Terms
Men who have sex with men;Pre-exposure prophylaxis (PrEP);Stigma;Sub-Saharan Africa;Transfeminine persons
Study Design
Study Approach
Country of Study
Kenya
Publication Country
United States